ANP Technologies, Inc.
ANP Technologies, Inc. is a world leader in developing innovative nanobiotechnology-based products for applications related to immunogenicity, biodefense, biologic drug development/testing, medical diagnostics, and food safety testing. The company focuses on nanotherapeutics, rapid biothreat detection, and bioanalytical methods, with a mission to contribute to health, safety, and defense through advanced nanotechnology solutions.
Industries
Nr. of Employees
small (1-50)
ANP Technologies, Inc.
Newark, Delaware, United States, North America
Products
Multiplexed rapid lateral-flow biothreat detection kits
Assay strips configured for 1-, 2-, 5- or 10-plex detection of bacterial, viral and toxin targets in powders, environmental samples and aqueous matrices; designed to minimize hook-effect and enable small-volume sampling.
Handheld and automated optical readers (portable and autoreader)
Portable palm-sized readers and automated readers for scanning lateral-flow assays, performing quantitative analysis, storing images/results on removable media, and exporting data to PC.
High-sensitivity streptavidin/neutravidin ELISA plates with nano-orientation coating
Coated 96-well plates using nanoscale orientation chemistry to increase active coating efficiency for biotinylated molecules and enhance assay sensitivity while reducing reagent consumption.
Protein extraction / interfering-protein removal kits (nanoparticle-based)
Kits to prepare or supply functionalized nanoparticles that scavenge and remove endogenous interfering proteins from biological matrices prior to PK or immunogenicity assays, improving accuracy and reducing reagent use.
Immunogenicity ELISA kit and rapid immunogenicity lateral-flow assay
ELISA-based and rapid point-of-care kits for detection of anti-PEG and other anti-drug antibodies including positive control antibodies and reagents, with documented limits of detection and recommended storage conditions.
Protein labeling kits (biotinylation and digoxigenin labeling)
Do-it-yourself kits for conjugating biotin, digoxigenin or fluorescein to proteins with rapid QC strips, enabling construction of sandwich PK and immunogenicity assays.
Multiplexed rapid lateral-flow biothreat detection kits
Assay strips configured for 1-, 2-, 5- or 10-plex detection of bacterial, viral and toxin targets in powders, environmental samples and aqueous matrices; designed to minimize hook-effect and enable small-volume sampling.
Handheld and automated optical readers (portable and autoreader)
Portable palm-sized readers and automated readers for scanning lateral-flow assays, performing quantitative analysis, storing images/results on removable media, and exporting data to PC.
High-sensitivity streptavidin/neutravidin ELISA plates with nano-orientation coating
Coated 96-well plates using nanoscale orientation chemistry to increase active coating efficiency for biotinylated molecules and enhance assay sensitivity while reducing reagent consumption.
Protein extraction / interfering-protein removal kits (nanoparticle-based)
Kits to prepare or supply functionalized nanoparticles that scavenge and remove endogenous interfering proteins from biological matrices prior to PK or immunogenicity assays, improving accuracy and reducing reagent use.
Immunogenicity ELISA kit and rapid immunogenicity lateral-flow assay
ELISA-based and rapid point-of-care kits for detection of anti-PEG and other anti-drug antibodies including positive control antibodies and reagents, with documented limits of detection and recommended storage conditions.
Protein labeling kits (biotinylation and digoxigenin labeling)
Do-it-yourself kits for conjugating biotin, digoxigenin or fluorescein to proteins with rapid QC strips, enabling construction of sandwich PK and immunogenicity assays.
Services
Custom nanoparticle functionalization and extraction kit development
Preparation of nanoparticles functionalized with customer-supplied or provided binding agents for targeted removal of interfering endogenous proteins and for custom sample-prep workflows.
Assay development and analytical services for immunogenicity and PK testing
Support for ELISA and rapid lateral-flow immunogenicity assay design, kit configuration, positive-control reagents, and comparative validation with centralized methods.
Contract manufacturing and fulfillment for handheld rapid assays
Volume manufacturing, packaging, and delivery of multiplexed rapid assay kits and associated sampling kits under government contract vehicles.
Reader deployment, data capture and technical field support
Provision of handheld and automated reader hardware, software for result interpretation and data management, plus technical support for field troubleshooting and operator training.
Partnerships and licensing for therapeutic development
Collaborative licensing and co-development arrangements with academic centers and commercial partners to advance targeted therapies and nanoformulated drugs toward clinical development.
Custom nanoparticle functionalization and extraction kit development
Preparation of nanoparticles functionalized with customer-supplied or provided binding agents for targeted removal of interfering endogenous proteins and for custom sample-prep workflows.
Assay development and analytical services for immunogenicity and PK testing
Support for ELISA and rapid lateral-flow immunogenicity assay design, kit configuration, positive-control reagents, and comparative validation with centralized methods.
Contract manufacturing and fulfillment for handheld rapid assays
Volume manufacturing, packaging, and delivery of multiplexed rapid assay kits and associated sampling kits under government contract vehicles.
Reader deployment, data capture and technical field support
Provision of handheld and automated reader hardware, software for result interpretation and data management, plus technical support for field troubleshooting and operator training.
Partnerships and licensing for therapeutic development
Collaborative licensing and co-development arrangements with academic centers and commercial partners to advance targeted therapies and nanoformulated drugs toward clinical development.
Expertise Areas
- Nanoparticle drug delivery and formulation
- Rapid lateral-flow immunoassay development (multiplex formats)
- Biodefense and biothreat detection
- Immunogenicity testing and assay development
Key Technologies
- Nanoencapsulation / nanoparticle drug delivery
- Poly(2-oxazoline)-based polymer excipients (polymer excipients for nanoformulations)
- Lateral-flow immunoassays (multiplexed)
- Nanoparticle-based protein extraction / sample cleanup